Cancers are among the leading causes of morbidity and mortality in the world.The purpose of this study was to conduct a survey on the effect of minerals on cancer risk in the Algerian population. One hundred and seventy-eight plasma samples were used to analyze the concentrations of iron (Fe), copper (Cu), and zinc (Zn) in cancerous patients and also in healthy subjects using the X-ray florescence technique (XRF). Samples were classified according to the age and gender of the donors. An empirical formula was developed for the concentration of Zinc, Copper and Iron in cancer patients according to the age. The averages iron, copper and zinc concentrations in mg/kg for control and Cancer disease groups were (1493 ± 105; 1496 ± 86), (1172 ± 229; 1078 ± 283) and (1266 ± 202; 1344 ± 208) respectively. The ANOVA One-Way test was applied. For both genders of control and cancer disease groups it shows a significant decrease rate of copper for global and female gender and a significant increase rate of zinc for global and male gender (p < 0.05). The results indicate that the Cu and Zn concentration could show helpful tools for diagnosis and preventive treatment of cancer diseases.

This publication presents an overview of the major topics and issues to be considered when planning and implementing treatment as it applies to cancer care in Algeria, and access to prevention, screening, palliative, and treatment services. Situational analysis related to cancer shows that Algeria has significant advantages in terms of infrastructure, equipment, human resources, and even financial resources. Given the recent implementation of the national cancer plan, this analysis provides valuable initial insight into the demographic and clinical characteristics of patients with cancer. The data provides a comprehensive picture of the fight against cancer with a focus on oncology. Better efforts should be made in the field of prevention, detection, and treatment for patients regardless of their age, health, or resources.Future investment in the field of cancer should strengthen the impact of the national capacities; the performance should be more than ever on the agenda of the national health authorities to achieve two goals, such as reducing cancer related mortality and reducing cancer incidence.The main objective is to stress the importance of being as close as possible to healthcare professionals and help them treat their patients better through training, not just new products, or technologies, but to think about sustainable strategies that look towards the future lying in precision and individualized healthcare.

No abstract

No abstract

No abstract

No abstract